Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
Novy
Jan
J
Rosselet
Anne
A
Spertini
Olivier
O
Lobrinus
Johannes Alexander
JA
Pabst
Thomas
T
Kuntzer
Thierry
T
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D017696:Myopathies, Nemaline / Q000188:drug therapy*; D010265:Paraproteinemias / Q000188:drug therapy*; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan